Table 3.
Cost saving and cost avoidance classified by interventions (Study group)
| Intervention | No. of Interventions n = 127 (%) | Cost Saving (USD) | Cost Avoidance (USD) | Total cost Saved and avoided (USD) |
|---|---|---|---|---|
| Missing required information on written prescriptions/orders | 33 (25.98) | -306.28 | -18.02 | -324.30 |
| Team initiated request for help (e.g. drug storage, compatibility, etc.) | 27 (21.26) | 0.00 | -8.48 | -8.48 |
| Adjust dose per renal dosing guideline | 20 (15.75) | -599.97 | -167.98 | -767.95 |
| Drug-drug interactions | 10 (7.87) | 0.00 | -12.72 | -12.72 |
| Recommend antibiotic coverage (empiric therapy, change or discontinue after culture and sensitivity result, and length of therapy) | 10 (7.87) | -875.42 | -14.31 | -889.72 |
| Recommend supplement therapy (e.g. K, Mg, Ca) | 9 (7.09) | 30.24 | -16.96 | 13.28 |
| Inappropriate schedule, dose, rate, or frequency prescribed for indication | 7 (5.51) | -69.53 | -38.15 | -107.68 |
| TPN/Enteral nutrition monitoring/intervention | 3 (2.36) | 9.96 | -0.53 | 9.43 |
| Recommend switching route of administration as appropriate (e.g. IV to PO when NG out) | 2 (1.57) | -160.43 | 0.00 | -160.43 |
| Recommend to check laboratory for appropriate therapy | 2 (1.57) | 0.00 | -5.83 | -5.83 |
| Recommend stopping contraindicated drugs | 1 (0.79) | 0.00 | -0.53 | -0.53 |
| Wrong unit of measure (e.g. mg instead of mcg) | 1 (0.79) | 0.00 | -5.30 | -5.30 |
| Miscellaneous | 2 (1.57) | 0.00 | -5.83 | -5.83 |
| Total | 127 (100) | -1,971.43 | -294.62 | -2,266.05 |
- indicated decrease cost of drug therapy